Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA8 | P11142 | 4/20 | 0.68 |
| ▸ | HSPA5 | P11021 | 3/20 | 0.68 |
| ▸ | GAPDH | P04406 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | HBB | P68871 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.59 |
| ▸ | SLC28A2 | O43868 | 3/20 | 0.58 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.58 |
| ▸ | NADK | O95544 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13835106 | 0.87 | GAPDH (0.70) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL13835110 | 0.87 | GAPDH (0.70) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL6761772 | 0.85 | HSPA8 (0.73) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL6761778 | 0.85 | HSPA8 (0.73) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL4754902 | 0.84 | SLC28A2 (0.64) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL7258957 | 0.83 | HSPA8 (0.66) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL30316415 | 0.83 | CYP3A4 (0.67) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL7258948 | 0.83 | HSPA8 (0.66) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL3485985 | 0.83 | CYP3A4 (0.67) | HSPA8HSPA5GAPDHHSD17B10RXFP1 | |
| SCHEMBL578218 | 0.83 | CYP3A4 (0.67) | HSPA8HSPA5GAPDHHSD17B10RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003051881-A1 | SUBSTITUTED PURINE NUCLEOSIDE LIBRARIES AND COMPOUNDS BY SOLID-PHASE COMBINATORIAL STRATEGIES | RIBAPHARM INC. (US) | 2003-06-26 | — | — | WO | disclosed |